Related Experiment Video
Updated: Jan 10, 2026
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Analysis of risk factors for Clostridioides difficile infection in patients with ulcerative colitis and development
1Department of Gastroenterology, Ganzhou People's Hospital, No.16 Meiguan Avenue, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China.
Objective:
This study aimed to identify the risk factors associated with Clostridioides difficile infection (CDI) in patients with ulcerative colitis (UC) and to develop a predictive nomogram.
Methods:
We prospectively enrolled 331 UC patients from April 2022 to October 2024. We randomly assigned them to a training set (n = 232) and a validation set (n = 99) in a 7:3 ratio. In the training set, there were 51 patients had CDI (CDI group) and 181 patients did not (non-CDI group). Clinical data were recorded. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) to screen risk factors for CDI in UC patients. R software was used to construct a nomogram model for predicting CDI. The calibration curve evaluated the model's calibration, while Receiver operating characteristic (ROC) curve assessed its discriminative power. Clinical decision curve analysis was conducted to evaluate clinical utility.
Results:
Age, obesity prevalence, and use of infliximab and glucocorticoids were higher in the CDI group compared to the non-CDI group, and albumin levels were lower (P < 0.05). Increased age, obesity, use of infliximab and glucocorticoids, and decreased albumin were independent risk factors for UC with CDI (P < 0.05). The training and validation sets showed that the calibration curve fitted well with the ideal curve, and the area under the ROC curve (AUC) was 0.930 and 0.877, respectively, indicating good calibration and discrimination. Clinical decision curve analysis showed high clinical effectiveness.
Conclusion:
The proposed nomogram demonstrated excellent performance in predicting CDI risk among patients with UC.
More Related Videos
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...